Aryloxyethylamines: Binding at α7 nicotinic acetylcholine receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 16, 2006, Pages 4283-4286

  Ragab, Hanan M ^a   Kim, Jin Sung ^a   Dukat, Małgorzata ^a   Navarro, Hernán ^b   Glennon, Richard A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

AXPQ; Nicotinic receptors

Indexed keywords

3 [2 (N,N,N TRIMETHYLAMMONIUM)ETHOXY]PYRIDINE; 6 (2 PHENYLETHYL)NICOTINE; ETHYLAMINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; 3 (2 (N,N,N TRIMETHYLAMMONIUM)ETHOXY)PYRIDINE; 3-(2-(N,N,N-TRIMETHYLAMMONIUM)ETHOXY)PYRIDINE; ALPHA-BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR; CHOLINE; DRUG DERIVATIVE; ETHER DERIVATIVE; PYRIDINE DERIVATIVE;

ARTICLE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; RECEPTOR AFFINITY; STRUCTURAL HOMOLOGY; CHEMICAL MODEL; CHEMISTRY; DRUG DESIGN; KINETICS; TEMPERATURE;

CHEMISTRY, PHARMACEUTICAL; CHOLINE; DRUG DESIGN; ETHERS; ETHYLAMINES; KINETICS; MODELS, CHEMICAL; NICOTINIC ANTAGONISTS; PYRIDINES; RECEPTORS, NICOTINIC; TEMPERATURE;

EID: 33745780299     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.05.080     Document Type: Article

References (21)

1. Glennon R.A. Prog. Med. Chem. 42 (2004) 55
2. Martin L.F., Kem W.R., and Freedman R. Psychopharmacology 174 (2004) 54
3. Summers K.L., Kem W.R., and Giacobini E. Jpn. J. Pharmacol. 74 (1997) 139
4. Aznar S., Kostova V., Christiansen S.H., and Knudsen G.M. Synapse 55 (2005) 196
5. Ramunno A., Dukat M., Lee M., Young R., El-Zahabi M., Damaj M.I., Martin B., and Glennon R.A. Bioorg. Med. Chem. Lett. 15 (2005) 3237
6. Simsek R., Chang-Fong J., Lee M., Damaj M.I., Martin B.R., and Glennon R.A. Bioorg. Med. Chem. Lett. 13 (2003) 2917
7. Gotti C., Carbonnelle E., Moretti M., Zwart R., and Clementi F. Behav. Brain Res. 113 (2000) 183
8. Gotti C., Balestra B., Moretti M., Rovati G.E., Maggi L., Rossoni G., Berti F., Villa L., Pallavicini M., and Clementi F. Br. J. Pharmacol. 124 (1998) 1197
9. Cheng Y., Dukat M., Dowd M., Fiedler W., Martin B., Damaj M.I., and Glennon R.A. Eur. J. Med. Chem. 34 (1999) 177
10. Glennon R.A., and Dukat M. In: Arneric S.P., and Brioni J.D. (Eds). Neuronal Nicotinic Receptors (1999), Wiley-Liss, New York 271-284
11. Molander G.A., and Bernardi C.R. J. Org. Chem. 67 (2002) 8424
12. 6 as solvent indicative of a common environment. Furthermore, the signals were nearly identical to that found for 5f (δ 3.19; s, 9H) which can only undergo methylation at one position.
13. Schinckaneder, H.; Loesen, R.; Grill, H. German Patent DE 3239610, 1984.
14. Massarani A. Il Farmaco 12 (1957) 380
15. Gündisch D., Andrä M., Munoz L., and Tilotta M.C. Bioorg. Med. Chem. 12 (2004) 4953
16. Bodnar A.L., Cortes-Burgos L.A., Cook K.K., Dinh D.M., Groppi V.E., Hajos M., Higdon N.R., Hoffmann W.E., Hurst R.S., Myers J.K., Rogers B.N., Wall T.M., Wolfe M.L., and Wong E. J. Med. Chem. 48 (2005) 905
17. Tatsumi R., Fujio M., Satoh H., Katayama J., Takanashi S., Hashimoto K., and Tanaka H. J. Med. Chem. 48 (2005) 2678
18. Mazurov A., Klucik J., Miao L., Phillips T.Y., Seamans A., Schmitt J.D., Hauser T.A., Johnson Jr. R.T., and Miller C. Bioorg. Med. Chem. Lett. 15 (2005) 2073
19. i value was repeated the SD was under 10%.
20. Navarro H.A., Zhong D., Abraham P., Xu H., and Carroll F.I. J. Med. Chem. 43 (2000) 142
21. Cheng Y., and Prusoff W.H. Biochem. Pharmacol. 22 (1973) 3099